HALO - Halozyme Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

HALO is currently covered by 8 analysts with an average price target of $71.62. This is a potential upside of $6.43 (9.86%) from yesterday's end of day stock price of $65.19.

Halozyme Therapeutics's activity chart (see below) currently has 231 price targets and 167 ratings on display. The stock rating distribution of HALO is 30% HOLD, 66.67% BUY and 3.33% SELL.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 91.3% with an average time for these price targets to be met of 291.84 days.

Highest price target for HALO is $90, Lowest price target is $53, average price target is $73.75.

Most recent stock forecast was given by JESSICA FYE from JPMORGAN on 27-Oct-2025. First documented stock forecast 11-Jun-2014.

Currently out of the existing stock ratings of HALO, 9 are a HOLD (30%), 20 are a BUY (66.67%), 1 are a SELL (3.33%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold

$65

$-0.19 (-0.29%)

$63

6 days ago
(27-Oct-2025)

11/11 (100%)

$-0.85 (-1.29%)

70

Buy

$79

$13.81 (21.18%)

$80

13 days ago
(20-Oct-2025)

8/10 (80%)

$12.53 (18.85%)

234

Sell

$70

$4.81 (7.38%)

$42

19 days ago
(14-Oct-2025)

3/4 (75%)

$3.35 (5.03%)

453

Buy

$90

$24.81 (38.06%)

$85

1 months ago
(02-Oct-2025)

31/33 (93.94%)

$18.31 (25.54%)

183

Buy

$90

$24.81 (38.06%)

$75

1 months 9 days ago
(24-Sep-2025)

6/7 (85.71%)

$14.36 (18.98%)

253

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is HALO (Halozyme Therapeutics) average time for price targets to be met?

On average it took 291.84 days on average for the stock forecasts to be realized with a an average price target met ratio 91.3

Which analyst has the current highest performing score on HALO (Halozyme Therapeutics) with a proven track record?

JASON BUTLER

Which analyst has the most public recommendations on HALO (Halozyme Therapeutics)?

Jason Butler works at JMP and has 6 price targets and 4 ratings on HALO

Which analyst is the currently most bullish on HALO (Halozyme Therapeutics)?

Robert Wasserman with highest potential upside - $24.81

Which analyst is the currently most reserved on HALO (Halozyme Therapeutics)?

Eun Yang with lowest potential downside - -$52.19

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?